Pharmaceutical Technology on MSN
Trump administration ties pricing deals with another nine pharma companies
With the latest batch’s agreements, only three out of the 17 drugmakers initially targeted by Trump have not signed pricing ...
GlobalData on MSN
Pharma positions itself for 2026 amid an evolving US landscape
From tariffs and onshoring to MFN, the US has seen significant policy developments - but how will these impact pharma in 2026?
Define Ventures’ new report provides a clear framework for how enterprise healthcare, particularly Big Pharma, is transitioning from AI exploration to execution. It focuses on core categories, ...
Mandy Vink, VP of Business Development at Codexis, explains how the company leverages over 20 years of expertise in small-molecule APIs to advance biocatalysis across pharma.
As pharmaceutical markets become more specialized and competitive, commercial and medical affairs teams must use technology and collaboration to make faster, better-informed decisions, Lance Hill, ...
Based on research and analysis of the global microecology market, as well as the evaluation of relevant companies in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback